Wall Street Signals: $PAOG PAOgroup PAOG Financial Report Compliance Expected Soon Following Recent CBD Biotech Acquisitions

$PAOG PAOgroup PAOG Financial Report Compliance Expected Soon Following Recent CBD Biotech Acquisitions

 


PAO Group, Inc. (OTC Pink: PAOG) confirmed today that the company expects to soon have its public disclosures in compliance with OTC Markets "Current Information" reporting standard. The efforts underway are expected to see the company back in compliance no later than by the end of this month.


PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the CBD biopharmaceutical sector. The revitalization strategy includes updating the company's financial statements to make the company compliant with the OTC Markets' "Current Information" reporting standard.

www.paogroupinc.com.

Forward-Looking Statements: Certain announcements in this news delivery may contain forward-glimpsing data inside the importance of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are dependent upon the protected harbor made by those standards. All announcements, other than articulations of reality, remembered for this delivery, including, without constraint, proclamations in regards to expected tentative arrangements and destinations of the organization are forward-looking explanations that include dangers and vulnerabilities. There can be no confirmation that such explanations will end up being precise and real outcomes and future occasions could vary physically from those foreseen in such articulations. Specialized difficulties, which may emerge, could forestall the brief execution of any deliberately critical plan(s) plot above. The Company embraces no obligation to change or update any forward-looking proclamations to reflect occasions or conditions after the date of this delivery.

CONTACT INFORMATION

Contact Us:
Jim DiPrima
888-272-6472
info@pao.group